NCT06096701

Brief Summary

Hypertensive disorders (HD), including preeclampsia, gestational hypertension, chronic hypertension, and chronic hypertension with superimposed preeclampsia, affect around 10-20% of pregnant women in the United States and are significantly associated with maternal mortality and morbidity, particularly in the postpartum period. The prevalence of HD is on the rise in the United States and has increased from 13% in 2017 to 16% in 2019 owing to an increase in advanced maternal age, obesity, and diabetes. There are major racial disparities in HD and subsequent maternal mortality and morbidity. HD affect more than 1 in 5 delivery hospitalizations of Black women. Black women with HD are also more likely than white women with HD to have more adverse postpartum blood pressure trajectories which leads to a higher incidence of hypertension related hospital readmissions (readmission for hypertension during the first 6-weeks postpartum: 16.9% among Black women vs. 9.5% among white women, p=0.02) and cardiovascular-related adverse events. However, most of the management recommendations have been centered around blood pressure targets during the antepartum period with significantly less attention paid to the postpartum period despite evidence showing that hypertensive disorders are the most common reason for postpartum readmissions and are associated with increased maternal mortality and morbidity and a significant cost burden.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
540

participants targeted

Target at P75+ for all trials

Timeline
26mo left

Started Feb 2024

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress51%
Feb 2024Jul 2028

First Submitted

Initial submission to the registry

October 17, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 24, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

February 13, 2024

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2027

Expected
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2028

Last Updated

March 18, 2026

Status Verified

March 1, 2026

Enrollment Period

3 years

First QC Date

October 17, 2023

Last Update Submit

March 16, 2026

Conditions

Keywords

PreeclampsiaGestational hypertensionEclampsiaChronic hypertension

Outcome Measures

Primary Outcomes (1)

  • Blood pressure ascertainment

    BP ascertainment i.e., percent of patients submitting at least one BP value, the average number of unique BP measures per patient during the first six-weeks postpartum, and percent of patients continuing the program beyond 3 weeks postpartum.

    First 6 weeks postpartum

Secondary Outcomes (3)

  • Percent of patients attending an in-person postpartum visit

    First 8 weeks postpartum

  • Percent of patients readmitted to the hospital through 12 months postpartum

    12 months postpartum

  • Survey assessing patient's acceptability and satisfaction with the BP monitoring program

    First 8 weeks postpartum

Study Arms (2)

Intervention

Intervention group will receive blood pressure (BP) cuffs. The BP cuff is connected in a Health Insurance Portability and Accountability Act-compliant fashion to the patient's medical record, allowing for documentation and communication with the nurse and the care team. Alerts are triggered if a patient has not checked her BP for 3 days or when readings fall outside a specific threshold (high or low BP alerts). Based on these alerts, the nurse follows up with these patients and reminds them to take a reading. The nurse will also notify participants with elevated BP values to repeat their BP and will contact the participants by phone to discuss symptoms and antihypertensive medications. Patients will be managed based on a clinical algorithm for initiation of antihypertensive medications without the need for an outpatient visit if considered appropriate by the clinical provider.

Device: Blood pressure cuff

Historical or Concurrent controls

Individuals who had hypertensive disorders during pregnancy but who did not receive the BP cuffs will serve as the control group.

Interventions

The BP cuff is connected in a Health Insurance Portability and Accountability Act-compliant fashion to the patient's medical record, allowing for documentation and communication with the nurse and the care team. Alerts are triggered if a patient has not checked her BP for 3 days or when readings fall outside a specific threshold (high or low BP alerts). Based on these alerts, the nurse follows up with these patients and reminds them to take a reading. The nurse will also notify participants with elevated BP values to repeat their BP and will contact the participants by phone to discuss symptoms and antihypertensive medications. Patients will be managed based on a clinical algorithm for initiation of antihypertensive medications without the need for an outpatient visit if considered appropriate by the clinical provider.

Intervention

Eligibility Criteria

Age18 Years - 54 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Individuals who will deliver at Prisma Health Richland.

You may qualify if:

  • Pregnant individuals with hypertensive disorders
  • Speak English
  • At least 18 years old
  • Medicaid coverage
  • Between 20 weeks of pregnancy and 2 weeks postpartum
  • Postpartum admission at Prisma Health Richland with hypertensive disorder within 2 weeks postpartum

You may not qualify if:

  • Not planning to deliver at Prisma Health Richland
  • Less than 20 weeks of pregnancy
  • More than 2 weeks postpartum

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Prisma Health Richland

Columbia, South Carolina, 29203, United States

RECRUITING

MeSH Terms

Conditions

HypertensionPre-EclampsiaHypertension, Pregnancy-InducedEclampsia

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

October 17, 2023

First Posted

October 24, 2023

Study Start

February 13, 2024

Primary Completion (Estimated)

February 1, 2027

Study Completion (Estimated)

July 1, 2028

Last Updated

March 18, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations